Abstract:The excessive inflammation triggered by damage-associated molecular patterns (DAMPs) after myocardial infarction (MI) is responsible for the development of cardiac dysfunction and adverse remodeling, while the mechanisms by which inflammation is fine tuned remain to be fully elucidated. MicroRNA-21 (miR-21) has been shown to function in cardiovascular diseases, while its role in inflammatory responses and cardiac function post MI in mice remains unknown. Here, we found that miR-21 expression was markedly increased in border and infarct areas of cardiac tissues during the early inflammatory phase of MI model established by ligating the left-anterior descending coronary artery. MiR-21 knockout mice had decreased survival rates, worse cardiac dysfunction, and increased infarct and scar areas after MI compared with WT mice. MiR-21 knockout mice showed significantly higher levels of inflammatory cytokines including IL-1β, IL-6, and TNF-α in cardiac tissues, as well as infiltration of CD11b + monocytes/macrophages with higher expression level of inflammatory cytokines. MI induced the great release of high mobility group protein B1 (HMGB1) and heat shock protein 60 (HSP60) in cardiac tissue. MiR-21 deficiency significantly promoted the inflammatory cytokine production triggered by DAMPs in macrophages, whereas, miR-21 overexpression markedly inhibited the inflammatory cytokine production. Mechanistically, miR-21 deficiency enhanced p38 and NF-κB signaling activation in cardiac tissue post MI and macrophages treated with DAMPs. MiR-21 was found to directly target kelch repeat and BTB (POZ) domain containing 7 (KBTBD7), which promoted DAMP-triggered inflammatory responses in macrophages. Furthermore, KBTBD7 interacted with MKK3/6 and promoted their activation, which in turn enhanced the activation of downstream p38 and NF-κB signaling induced by DAMPs. Therefore, our findings demonstrate that miR-21 attenuates inflammation, cardiac dysfunction, and maladaptive remodeling post MI through targeting KBTBD7 and inhibiting p38 and NF-κB signaling activation, suggesting that miR-21 may function as a novel potential therapeutic target for MI.

[Microrna-21 Protects Cardiomyocytes from Tumor Necrosis Factor-Α Induced Apoptosis in Vitro Via Modulating PTEN/AKT/FOXO3a Pathway].

MicroRNA-21 prevents excessive inflammation and cardiac dysfunction after myocardial infarction through targeting KBTBD7

MicroRNA-21 Regulates Peroxisome Proliferator–activated Receptor Alpha, a Molecular Mechanism of Cardiac Pathology in Cardiorenal Syndrome Type 4

MicroRNA-21 Contributes to Liver Regeneration by Targeting PTEN

Abstract 49: Mir-21 Contributes to Cardiac Aging by Targeting Pten

Microrna-21 Promotes Cardiac Fibrosis And Development Of Heart Failure With Preserved Left Ventricular Ejection Fraction By Up-Regulating Bcl-2

Mir-21-5p Prevents Doxorubicin-Induced Cardiomyopathy by Downregulating BTG2

Microrna-182-5p Protects H9c2 Cardiomyocytes From Hypoxia-Induced Apoptosis By Down-Regulation Of Pten

Attenuation of MicroRNA‐22 Derepressed PTEN to Effectively Protect Rat Cardiomyocytes from Hypertrophy

Cardioprotective Effect of MicroRNA-21 in Murine Myocardial Infarction.

Mir-21 Protected Cardiomyocytes Against Doxorubicin-Induced Apoptosis by Targeting Btg2

Role of Mir-19B in Protecting Cardiomyocytes from Apoptosis by Activating Akt Signaling

Angiotensin II Type I Receptor Agonistic Autoantibodies Induces Apoptosis of Cardiomyocytes by Downregulating Mir21 in Preeclampsia: a Mechanism Study.

Effects of Down-Regulation of Microrna-23A on TNF-α-induced Endothelial Cell Apoptosis Through Caspase-Dependent Pathways

MicroRNA-101 Protects Cardiac Fibroblasts from Hypoxia-Induced Apoptosis Via Inhibition of the TGF-β Signaling Pathway

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

miR-19a protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis via PTEN/PI3K/p-Akt pathway

MiR-31a-5p Protects Myocardial Cells Against Apoptosis by Targeting Tp53.

Attenuation of MicroRNA-495 Derepressed PTEN to Effectively Protect Rat Cardiomyocytes from Hypertrophy

GW24-e3699 Rosuvastatin protects cardiomyocytes from tumour necrosis factor-alpha induced apoptosis via microRNA-210 up-regulation

MicroRNA-22 Targeting CBP Protects Against Myocardial Ischemia–reperfusion Injury Through Anti-Apoptosis in Rats